Intellia Therapeutics Inc header image

Intellia Therapeutics Inc

NTLA

Equity

ISIN US45826J1051 / Valor 32256913

NASDAQ (2024-11-22)

USD 14.30+3.62%

Intellia Therapeutics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Intellia Therapeutics Inc is a biotechnology company focused on developing curative genome editing treatments using CRISPR/Cas9 technology. Founded with the mission to transform the lives of people with severe diseases, Intellia collaborates with partners like Regeneron to explore in vivo applications of genome editing. The company's work in harnessing the potential of CRISPR to make specific changes in the DNA of humans, animals, and plants has captured global attention for its potential to revolutionize disease treatment. Led by co-founder Jennifer Doudna, Intellia is at the forefront of the genome editing field, working towards developing innovative therapies for a range of genetic disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-52.7%1Y

-88.5%3Y

-6.60%5Y

Performance

60.8%1Y

68.6%3Y

77.1%5Y

Volatility

2141 M

Market cap (USD)

1,327,940

Daily traded volume (Shares)

14.39 / 13.23

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Internet Thailand Public Company Limited

Internet Thailand Public Company Limited Valor: 1306191

Annual Return

-50%0%+50%

Risk level

110

-0.55%EUR 0.18

argenx SE

argenx SE Valor: 36542319

Annual Return

-50%0%+50%

Risk level

110

1.54%USD 605.92

First Solar Inc

First Solar Inc Valor: 2626060

Annual Return

-50%0%+50%

Risk level

110

2.25%USD 186.05

Santhera Pharmaceuticals Holding Ltd.

Santhera Pharmaceuticals Holding Ltd. Valor: 127602882

Annual Return

-50%0%+50%

Risk level

110

1.27%CHF 8.00

Doximity Inc

Doximity Inc Valor: 111921599

Annual Return

-50%0%+50%

Risk level

110

-3.81%USD 48.00

Teradyne Inc

Teradyne Inc Valor: 976541

Annual Return

-50%0%+50%

Risk level

110

2.55%USD 108.21

Duke Energy Corp

Duke Energy Corp Valor: 14115567

Annual Return

-50%0%+50%

Risk level

110

0.98%USD 114.86

Franklin Electric Co Inc

Franklin Electric Co Inc Valor: 931820

Annual Return

-50%0%+50%

Risk level

110

2.27%USD 109.06

Kanzhun Limited

Kanzhun Limited Valor: 111844659

Annual Return

-50%0%+50%

Risk level

110

-2.40%EUR 6.10

Entegris Inc

Entegris Inc Valor: 1102899

Annual Return

-50%0%+50%

Risk level

110

1.90%USD 107.24

SIX

FactSet

Clearbit

Logos provided by Clearbit